114 related articles for article (PubMed ID: 31109595)
1. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
Lima K; Coelho-Silva JL; Kinker GS; Pereira-Martins DA; Traina F; Fernandes PACM; Markus RP; Lucena-Araujo AR; Machado-Neto JA
Cancer Genet; 2019 Apr; 233-234():56-66. PubMed ID: 31109595
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia.
Lima K; Carvalho MFL; Pereira-Martins DA; Nogueira FL; de Miranda LBL; Nascimento MCD; Cavaglieri RC; Schuringa JJ; Machado-Neto JA; Rego EM
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069220
[TBL] [Abstract][Full Text] [Related]
3. A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival.
Jude JG; Spencer GJ; Huang X; Somerville TDD; Jones DR; Divecha N; Somervaille TCP
Oncogene; 2015 Mar; 34(10):1253-1262. PubMed ID: 24681948
[TBL] [Abstract][Full Text] [Related]
4. Differential profile of PIP4K2A expression in hematological malignancies.
Lima K; Ribeiro DM; Campos Pde M; Costa FF; Traina F; Saad ST; Sonati Mde F; Machado-Neto JA
Blood Cells Mol Dis; 2015 Oct; 55(3):228-35. PubMed ID: 26227852
[TBL] [Abstract][Full Text] [Related]
5. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia.
Lima K; Nogueira FL; Cipelli M; Carvalho MFL; Pereira-Martins DA; da Silva WF; Cavaglieri RC; Nardinelli L; Leal AM; Velloso EDRP; Bendit I; Câmara NOS; Schuringa JJ; Machado-Neto JA; Rego EM
Eur J Pharmacol; 2024 Jun; 977():176723. PubMed ID: 38851560
[TBL] [Abstract][Full Text] [Related]
6. Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase.
Kremer AN; Bausenwein J; Lurvink E; Kremer AE; Rutten CE; van Bergen CAM; Kretschmann S; van der Meijden E; Honders MW; Mazzeo D; Watts C; Mackensen A; Falkenburg JHF; Griffioen M
Front Immunol; 2020; 11():381. PubMed ID: 32218783
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Delivery of Pip4k2c-Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart.
Magadum A; Singh N; Kurian AA; Sharkar MTK; Sultana N; Chepurko E; Kaur K; Żak MM; Hadas Y; Lebeche D; Sahoo S; Hajjar R; Zangi L
Adv Sci (Weinh); 2021 May; 8(10):2004661. PubMed ID: 34026458
[TBL] [Abstract][Full Text] [Related]
8. Association of
Fedorenko OY; Mikhalitskaya EV; Toshchakova VA; Loonen AJM; Bokhan NA; Ivanova SA
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681036
[TBL] [Abstract][Full Text] [Related]
9. ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.
Bekker-Méndez VC; Núñez-Enríquez JC; Torres Escalante JL; Alvarez-Olmos E; González-Montalvoc PM; Jiménez-Hernández E; Sansón AM; Leal YA; Ramos-Cervantes MT; Guerra-Castillo FX; Ortiz-Maganda MP; Flores-Lujano J; Pérez-Saldivar ML; Velazquez-Aviña MM; Bolea-Murga V; Torres-Nava JR; Amador-Sanchez R; Solis-Labastida KA; Rámirez-Bello J; Fragoso JM; Mejía-Aranguré JM;
Arch Med Res; 2016 Nov; 47(8):623-628. PubMed ID: 28476190
[TBL] [Abstract][Full Text] [Related]
10. PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism.
Wang DG; Paddock MN; Lundquist MR; Sun JY; Mashadova O; Amadiume S; Bumpus TW; Hodakoski C; Hopkins BD; Fine M; Hill A; Yang TJ; Baskin JM; Dow LE; Cantley LC
Cell Rep; 2019 May; 27(7):1991-2001.e5. PubMed ID: 31091439
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the gene Pip4k2c, a novel phosphatidylinositol kinase, results in hyperactivation of the immune system.
Shim H; Wu C; Ramsamooj S; Bosch KN; Chen Z; Emerling BM; Yun J; Liu H; Choo-Wing R; Yang Z; Wulf GM; Kuchroo VK; Cantley LC
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7596-601. PubMed ID: 27313209
[TBL] [Abstract][Full Text] [Related]
12. Association analysis of the PIP4K2A gene on chromosome 10p12 and schizophrenia in the Irish study of high density schizophrenia families (ISHDSF) and the Irish case-control study of schizophrenia (ICCSS).
Thiselton DL; Maher BS; Webb BT; Bigdeli TB; O'Neill FA; Walsh D; Kendler KS; Riley BP
Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):323-31. PubMed ID: 19475563
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Enzyme SLC27A5 Regulates PIP4K2A pre-mRNA Splicing as a Noncanonical Mechanism to Suppress Hepatocellular Carcinoma Metastasis.
Nie D; Tang X; Deng H; Yang X; Tao J; Xu F; Liu Y; Wu K; Wang K; Mei Z; Huang A; Tang N
Adv Sci (Weinh); 2024 Feb; 11(5):e2305374. PubMed ID: 38059827
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
15. Distribution and localization of phosphatidylinositol 5-phosphate, 4-kinase alpha and beta in the brain.
Noch EK; Yim I; Milner TA; Cantley LC
J Comp Neurol; 2021 Feb; 529(2):434-449. PubMed ID: 32449185
[TBL] [Abstract][Full Text] [Related]
16. Association Between PIP4K2A Polymorphisms and Acute Lymphoblastic Leukemia Susceptibility.
Liao F; Yin D; Zhang Y; Hou Q; Zheng Z; Yang L; Shu Y; Xu H; Li Y
Medicine (Baltimore); 2016 May; 95(18):e3542. PubMed ID: 27149463
[TBL] [Abstract][Full Text] [Related]
17. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
[TBL] [Abstract][Full Text] [Related]
18. Regulatory Network and Prognostic Effect Investigation of PIP4K2A in Leukemia and Solid Cancers.
Zhang S; Li Z; Yan X; Bao L; Deng Y; Zeng F; Wang P; Zhu J; Yin D; Liao F; Zhou X; Zhang D; Xia X; Wang H; Yang X; Zhang W; Gao H; Zhang W; Yang L; Hou Q; Xu H; Zhang Y; Shu Y; Wang Y
Front Genet; 2018; 9():721. PubMed ID: 30697230
[TBL] [Abstract][Full Text] [Related]
19. Altered phenotypes due to genetic interaction between the mouse phosphoinositide biosynthesis genes Fig4 and Pip4k2c.
Cao X; Lenk GM; Meisler MH
G3 (Bethesda); 2023 Aug; 13(8):. PubMed ID: 36691351
[TBL] [Abstract][Full Text] [Related]
20. PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia.
Pashaiefar H; Yaghmaie M; Tavakkoly-Bazzaz J; Ghaffari SH; Alimoghaddam K; Momeny M; Izadi P; Izadifard M; Kasaeian A; Ghavamzadeh A
Genet Test Mol Biomarkers; 2018 Jun; 22(6):343-349. PubMed ID: 29812960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
